ZALMOXI - DDS

Zalmoxi-DDS is a dry syrup oral suspension that contains amoxycillin, a broad-spectrum penicillin antibiotic, and clavulanic acid, a beta-lactamase inhibitor. This dual drug system (DDS) formulation enhances antibacterial activity by protecting amoxycillin from enzymatic degradation. It is prescribed in pediatric patients for respiratory tract infections, ENT infections, urinary tract infections, skin and soft tissue infections, and gastrointestinal infections caused by susceptible bacteria. The DDS pack ensures stability and accurate dosing after reconstitution.